GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Pacific Biosciences of California Inc (STU:P09) » Definitions » Cyclically Adjusted PB Ratio

Pacific Biosciences of California (STU:P09) Cyclically Adjusted PB Ratio : 1.10 (As of Jun. 20, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Pacific Biosciences of California Cyclically Adjusted PB Ratio?

As of today (2024-06-20), Pacific Biosciences of California's current share price is €1.5754. Pacific Biosciences of California's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 was €1.43. Pacific Biosciences of California's Cyclically Adjusted PB Ratio for today is 1.10.

The historical rank and industry rank for Pacific Biosciences of California's Cyclically Adjusted PB Ratio or its related term are showing as below:

STU:P09' s Cyclically Adjusted PB Ratio Range Over the Past 10 Years
Min: 0.93   Med: 6.75   Max: 34
Current: 1.04

During the past years, Pacific Biosciences of California's highest Cyclically Adjusted PB Ratio was 34.00. The lowest was 0.93. And the median was 6.75.

STU:P09's Cyclically Adjusted PB Ratio is ranked better than
72.38% of 478 companies
in the Medical Devices & Instruments industry
Industry Median: 2.05 vs STU:P09: 1.04

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio. The Cyclically Adjusted Book per Share is the average of the inflation adjusted book value per share of a company over the past 10 years.

Pacific Biosciences of California's adjusted book value per share data for the three months ended in Mar. 2024 was €2.193. Add all the adjusted book value per share for the past 10 years together and divide the count will get our Cyclically Adjusted Book per Share, which is €1.43 for the trailing ten years ended in Mar. 2024.

Shiller PE for Stocks: The True Measure of Stock Valuation


Pacific Biosciences of California Cyclically Adjusted PB Ratio Historical Data

The historical data trend for Pacific Biosciences of California's Cyclically Adjusted PB Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Pacific Biosciences of California Cyclically Adjusted PB Ratio Chart

Pacific Biosciences of California Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted PB Ratio
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.45 17.56 15.36 5.88 6.43

Pacific Biosciences of California Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted PB Ratio Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 8.12 9.14 5.56 6.43 2.38

Competitive Comparison of Pacific Biosciences of California's Cyclically Adjusted PB Ratio

For the Medical Devices subindustry, Pacific Biosciences of California's Cyclically Adjusted PB Ratio, along with its competitors' market caps and Cyclically Adjusted PB Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Pacific Biosciences of California's Cyclically Adjusted PB Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Pacific Biosciences of California's Cyclically Adjusted PB Ratio distribution charts can be found below:

* The bar in red indicates where Pacific Biosciences of California's Cyclically Adjusted PB Ratio falls into.



Pacific Biosciences of California Cyclically Adjusted PB Ratio Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted PB Ratio takes the Book Value per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/B calculation. Because it considers this 10-year average, it's often referred to as the CAPB Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted PB Ratio.

Pacific Biosciences of California's Cyclically Adjusted PB Ratio for today is calculated as

Cyclically Adjusted PB Ratio=Share Price/ Cyclically Adjusted Book per Share
=1.5754/1.43
=1.10

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Pacific Biosciences of California's Cyclically Adjusted Book per Share for the quarter that ended in Mar. 2024 is calculated as:

For example, Pacific Biosciences of California's adjusted Book Value per Share data for the three months ended in Mar. 2024 was:

Adj_Book=Book Value per Share/CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=2.193/131.7762*131.7762
=2.193

Current CPI (Mar. 2024) = 131.7762.

Pacific Biosciences of California Quarterly Data

Book Value per Share CPI Adj_Book
201406 0.615 100.560 0.806
201409 0.580 100.428 0.761
201412 0.603 99.070 0.802
201503 0.502 99.621 0.664
201506 0.402 100.684 0.526
201509 0.487 100.392 0.639
201512 0.844 99.792 1.115
201603 0.916 100.470 1.201
201606 1.061 101.688 1.375
201609 0.949 101.861 1.228
201612 0.866 101.863 1.120
201703 0.692 102.862 0.887
201706 0.892 103.349 1.137
201709 0.732 104.136 0.926
201712 0.626 104.011 0.793
201803 0.632 105.290 0.791
201806 0.555 106.317 0.688
201809 0.759 106.507 0.939
201812 0.667 105.998 0.829
201903 0.550 107.251 0.676
201906 0.438 108.070 0.534
201909 0.303 108.329 0.369
201912 0.323 108.420 0.393
202003 0.355 108.902 0.430
202006 0.238 108.767 0.288
202009 0.611 109.815 0.733
202012 1.434 109.897 1.719
202103 1.188 111.754 1.401
202106 1.078 114.631 1.239
202109 3.241 115.734 3.690
202112 3.168 117.630 3.549
202203 2.973 121.301 3.230
202206 2.870 125.017 3.025
202209 2.801 125.227 2.948
202212 2.346 125.222 2.469
202303 2.588 127.348 2.678
202306 2.366 128.729 2.422
202309 2.770 129.860 2.811
202312 2.402 129.419 2.446
202403 2.193 131.776 2.193

Add all the adjusted book value per share together and divide the count will get our Cyclically Adjusted Book per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Pacific Biosciences of California  (STU:P09) Cyclically Adjusted PB Ratio Explanation

Compared with the regular PB Ratio, which works poorly for cyclical businesses, the Cyclically Adjusted PB Ratio smoothed out the fluctuations of book value during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted PB Ratio should give similar results to regular PB Ratio.


Pacific Biosciences of California Cyclically Adjusted PB Ratio Related Terms

Thank you for viewing the detailed overview of Pacific Biosciences of California's Cyclically Adjusted PB Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.


Pacific Biosciences of California (STU:P09) Business Description

Traded in Other Exchanges
Address
1305 O’Brien Drive, Menlo Park, CA, USA, 94025
Pacific Biosciences of California Inc is a biotechnology company focused on the design, development, and commercialization of tools for biological research. The company develops sequencing systems to assist in resolving genetically complex problems. Its sequencing systems provide access to a wide range of applications and are designed for expandable improvements to performance capability. The majority of the company's revenue is derived from North America, followed by Asia and Europe.

Pacific Biosciences of California (STU:P09) Headlines

No Headlines